Darling Helen 4
4 · Teladoc Health, Inc. · Filed Jun 9, 2020
Insider Transaction Report
Form 4
Darling Helen
Director
Transactions
- Sale
Common Stock
2020-06-05$151.30/sh−28,120$4,254,556→ 918 total - Exercise/Conversion
Common Stock
2020-06-05$16.64/sh+28,120$467,917→ 29,038 total - Exercise/Conversion
Stock Option (right to buy)
2020-06-05−28,120→ 0 totalExercise: $16.64Exp: 2026-08-08→ Common Stock (28,120 underlying)
Footnotes (2)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on May 6, 2020.
- [F2]The option vested in three equal annual installments beginning August 8, 2017.